pharma · Hemophilia A With Inhibitor · Hemophilia A · CPRX
CATALYST PHARMACEUTICALS
CATALYST PHARMACEUTICALS, INC.
CATALYST PHARMACEUTICALS clinical programs — 23 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, US
- Founded
- 2002
- Employees
- 179
- Programs
- 23
- Drugs
- 20
- Patents
- 61
CATALYST PHARMACEUTICALS projects
23 ClinicalTrials.gov programs sponsored by CATALYST PHARMACEUTICALS.
CATALYST PHARMACEUTICALS has 23 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Amifampridine Phosphate
CATALYST PHARMACEUTICALS, INC.
Myasthenia Gravis, Generalized
1 trial -
Amifampridine Phosphate
CATALYST PHARMACEUTICALS, INC.
Myasthenia Gravis, MuSK
1 trial -
Amifampridine Phosphate
CATALYST PHARMACEUTICALS, INC.
Lambert Eaton Myasthenic Syndrome
2 trials -
BT-001
CATALYST PHARMACEUTICALS, INC.
Type2 Diabetes
1 trial -
MarzAA
CATALYST PHARMACEUTICALS, INC.
Hemophilia A With Inhibitor
1 trial -
amifampridine phosphate
CATALYST PHARMACEUTICALS, INC.
Myasthenic Syndromes, Congenital
1 trial -
Amifampridine Phosphate
CATALYST PHARMACEUTICALS, INC.
Muscular Atrophy, Spinal
1 trial -
Amifampridine Phosphate 10 MG Oral Tablet
CATALYST PHARMACEUTICALS, INC.
Spinal Muscular Atrophy Type 3
1 trial -
CPP-109 vigabatrin
CATALYST PHARMACEUTICALS, INC.
Methamphetamine Dependence
1 trial -
Coagulation Factor IX variant
CATALYST PHARMACEUTICALS, INC.
Hemophilia B
1 trial -
Coagulation Factor VIIa variant
CATALYST PHARMACEUTICALS, INC.
Factor VII Deficiency
1 trial -
Coagulation Factor VIIa variant
CATALYST PHARMACEUTICALS, INC.
Hemophilia A With Inhibitor
1 trial -
Decitabine
CATALYST PHARMACEUTICALS, INC.
Acute Myeloid Leukemia
1 trial -
Dupilumab
CATALYST PHARMACEUTICALS, INC.
COVID-19
1 trial -
MHS-1031
CATALYST PHARMACEUTICALS, INC.
Gastroesophageal Reflux
1 trial -
vigabatrin
CATALYST PHARMACEUTICALS, INC.
Cocaine Dependence
2 trials -
Airway Bypass
CATALYST PHARMACEUTICALS, INC.
Emphysema or COPD
1 trial -
Bumetanide
CATALYST PHARMACEUTICALS, INC.
Seizures
1 trial -
CPP-115
CATALYST PHARMACEUTICALS, INC.
Cocaine Dependency
1 trial -
HWK-016, MUCIN-16-targeted ADC
CATALYST PHARMACEUTICALS, INC.
PROC
1 trial -
ISU304/CB2679d/Dalcinonacog alfa 75~150 IU/kg
CATALYST PHARMACEUTICALS, INC.
Hemophilia B
1 trial -
MarzAA (marzeptacog alfa [activated])
CATALYST PHARMACEUTICALS, INC.
Hemophilia A
1 trial -
PF-05280602
CATALYST PHARMACEUTICALS, INC.
Hemophilia A
1 trial
Frequently asked questions
How many clinical projects does CATALYST PHARMACEUTICALS have?
23 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.